Sectinomycin in the treatment of gonorrhoea in females and males.
AUTOR(ES)
Finger, A H
RESUMO
126 female patients with proven gonococcal infection were treated with 4 g. spectinomycin bihydrochloride given intramuscularly in a single does. In 120 cases followed up there were four possible treatment failures, giving a cure rate of 97-6 per cent. 99 male patients with acute gonococcal urethritis were treated with a single dose of 2, g. sectinomycin bihydrochloride. Of 88 cases followed up, there were three possible treatment failures, giving a cure rate of 96-6 per cent. Spectinomycin is an important addition to gonorrhoea therapy but should be reserved for penicillin sensitive patients and penicillin insensitive infections.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=1045107Documentos Relacionados
- Spectinomycin in the treatment of gonorrhoea in males.
- Spectinomycin hydrochloride in the treatment of uncomplicated gonorrhoea in males and females.
- 'Triple tetracycline' in the treatment of non-gonococcal urethritis in males.
- Gentamicin in the treatment of gonorrhoea in females.
- Rectal gonorrhoea as an independent risk factor for HIV infection in homosexual males.
